Teliatry logo — Advanced Neuromodulation Therapy Development, brought to you...

Teliatry

Advanced Neuromodulation Therapy Development, brought to you with scalable, 21st century, manufacturing technology.

Founded 2018 United States Richardson, United States 7 employees

General Information

Company Name Teliatry
Founded Year 2018
Location United States Richardson, United States +1
Employees 7
Social

Get notified when Teliatry moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Teliatry

Teliatry is a fast-growing startup aimed at disrupting the medical device industry. We are an ISO 13485:2016 and ISO 9001: 2015 certified medical device manufacturer that designs, develops and manufactures next generation minimally invasive, implantable medical device systems for the neuromodulation, deep brain stimulation, drug delivery, sensing, and multiparameter medical systems global market. Teliatry was founded by members of two pioneers in biomedical device R&D: the Texas Biomedical Device Center (TXBDC) and Zyvex Labs. The company that has emerged from the combined talent and technology of these organizations is revolutionizing biomedical device manufacturing with highly miniaturized and sophisticated class III implants built with 21st century, scalable manufacturing techniques. We have developed a platform technology which we provide as a contract biomedical device manufacturer for biomedical device companies that need minimally invasive, injectable, or highly miniaturized implant systems. Our initial device is a wireless neurostimulator system developed for vagus nerve stimulation. It is implantable with minimally invasive surgery, has an embedded programmable CPU, has undergone extensive biocompatibility and animal studies and is 30X smaller than products in the market today. The system currently has FDA approval for three different early feasibility studies. We have a well-established supply chain for our manufacturing approach that is wafer scale, automated and highly scalable to large volumes, dramatically lowering the cost, while improving the capabilities and reliability over existing manufacturing approaches. The cost per implant system will permit animal studies with the same device that can be taken into human clinical trials saving time and money. This adaptable platform technology is being developed by our experienced and talented design team for an ever-expanding range of uses. Contact us to see what we can do for your therapeutics.

No funding data available for Teliatry yet.

Get notified when Teliatry raises funding

Teliatry Alternatives & Competitors

Teliatry vs
Radlink, Inc.
Radlink, Inc. United States

Medical Technology Innovator Designing Orthopedic Surgical Navigation Software #AIfortheOR

15 employees
Health Care, Medical Devices
Teliatry vs

Cleaner, faster & easier tests with operator-free medical devices

41 employees
Biotechnology, Digital Health
Teliatry vs

Making things happen better and smarter in the spinal surgery arena.

3 employees
Biotechnology, Health Care

FAQ About Teliatry

Advanced Neuromodulation Therapy Development, brought to you with scalable, 21st century, manufacturing technology.
Teliatry was founded in 2018.
Teliatry is headquartered in Richardson, United States.
Teliatry has approximately 7 employees.
Top alternatives and competitors to Teliatry include Radlink, Inc., Oruba Health, Spinal Resources Incorporated, NeuroPace, Profound Medical Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Teliatry and Radlink, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Teliatry and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy